HealthTree Logo
search more_vert
person Sign In / Create Account
Know Your Myeloma Immunotherapy: Antibody Drug Conjugates with Dr. Jesus Berdeja
Know Your Myeloma Immunotherapy: Antibody Drug Conjugates with Dr. Jesus Berdeja image
Immunotherapy (CAR T, Bispecifics and more) Treatment
event May 24, 2022 / 01:00PM - 02:00PM EDT

Event Description

 Learn how antibody drug conjugates can help fight myeloma through the expertise of Dr. Jesus Berdeja. What is the mechanism of action? Which types of antibody drug conjugates are FDA approved? What is their side effect profile? What is the future of ADCs in myeloma? Learn more with us and come with your questions. 

Schedule & Agenda

Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. Jesus Berdeja.
Dr. Jesus Berdeja
Learn about how antibody drug conjugates can help fight myeloma and if you consider them in your myeloma treatment.
Questions and Answers
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Dr. Jesus Berdeja
Dr. Jesus Berdeja

Jesus G. Berdeja received his undergraduate degree from Stanford University and medical degree from Harvard University. He completed his internship and residency in the Department of Internal Medicine at the University of California in San Francisco and fellowships in medical oncology and hematology at Johns Hopkins University School of Medicine in Baltimore. Prior to joining the staff at the Sarah Cannon Research Institute and Tennessee Oncology, Dr. Berdeja held appointments in the Stem Cell and Bone Marrow Transplant Program and the Division of Hematology and Oncology at Loma Linda University in Loma Linda, California. Dr. Berdeja has been certified a Diplomate in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Additionally, he is an active member of several professional organizations, including the International Myeloma Society, the American Society of Clinical Oncology, the American Society of Hematology, the International Myeloma Working Group, the Clinical Trials Myeloma Intergroup Committee, and the Center for International Blood and Marrow Transplant Research Plasma Cell Working Group. An active researcher, Dr. Berdeja has been the principal investigator on a number of funded clinical trials in the field of multiple myeloma. He has published extensively in the peer-reviewed literature and is a frequent invited lecturer.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook twitter